Literature DB >> 25708047

Pancreatic cancer: Disrupted lipid metabolic pathways in PDAC identified.

Claire Greenhill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25708047     DOI： 10.1038/nrgastro.2015.32

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma.

Authors:  Fabienne Guillaumond; Ghislain Bidaut; Mehdi Ouaissi; Stéphane Servais; Victoire Gouirand; Orianne Olivares; Sophie Lac; Laurence Borge; Julie Roques; Odile Gayet; Michelle Pinault; Cyrille Guimaraes; Jérémy Nigri; Céline Loncle; Marie-Noëlle Lavaut; Stéphane Garcia; Anne Tailleux; Bart Staels; Ezequiel Calvo; Richard Tomasini; Juan Lucio Iovanna; Sophie Vasseur
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205
  1 in total
  1 in total

1.  LDL Receptor: An open route to feed pancreatic tumor cells.

Authors:  Sophie Vasseur; Fabienne Guillaumond
Journal:  Mol Cell Oncol       Date:  2015-05-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.